Cytotoxicity of Graphene Oxide and Graphene Oxide Loaded with Doxorubicin on Human Multiple Myeloma Cells

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2014 Mar 28

PMID 24672235

Citations 29

Authors

Shaoling Wu

Xindong Zhao

Zhongguang Cui

Chunting Zhao

Yuzhen Wang

Li Du

Yanhui Li

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to evaluate the cytotoxicity of human multiple myeloma cells (RPMI-8226) treated with graphene oxide (GO), doxorubicin (DOX), and GO loaded with DOX (GO/DOX). Cell viability was determined using the Cell Counting Kit-8 assay and analyzing the cell cycle and cell apoptosis. Cells treated with GO, GO/DOX, and pure DOX for 24 hours showed a decrease in proliferation. GO/DOX significantly inhibited cell proliferation as compared with pure DOX (P<0.01). When the effects of GO were removed, there was no observed difference between GO/DOX and pure DOX (P>0.05). Flow cytometry analysis of untreated and GO-, DOX-, and GO/DOX-treated cells found no significant differences in the G0/G1 phase (P>0.05), while significant differences were observed in the total apoptotic rates (P<0.05). No significant differences existed in the total apoptotic rates of GO-treated and untreated cells (P>0.05). These findings suggest that GO caused low cytotoxicity and did not induce cell apoptosis or change the cell cycle in multiple myeloma cells. Moreover, GO did not affect the antitumor activity of DOX. In conclusion, GO would be suitable as an anticancer drug nanocarrier and used to treat hematological malignancies.

Citing Articles

Engineering Ag-Decorated Graphene Oxide Nano-Photothermal Platforms with Enhanced Antibacterial Properties for Promoting Infectious Wound Healing.

Sun Z, Chen X, Miao F, Meng N, Hu K, Xiong S Int J Nanomedicine. 2024; 19:8901-8927.

PMID: 39233743 PMC: 11372703. DOI: 10.2147/IJN.S474536.

Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells.

Rafe Hatshan M, Saquib Q, Siddiqui M, Faisal M, Ahmad J, Al-Khedhairy A Int J Mol Sci. 2023; 24(11).

PMID: 37298090 PMC: 10252622. DOI: 10.3390/ijms24119141.

Ginsenoside Rg3 Reduces the Toxicity of Graphene Oxide Used for pH-Responsive Delivery of Doxorubicin to Liver and Breast Cancer Cells.

Rahimi S, van Leeuwen D, Roshanzamir F, Pandit S, Shi L, Sasanian N Pharmaceutics. 2023; 15(2).

PMID: 36839713 PMC: 9965446. DOI: 10.3390/pharmaceutics15020391.

In vitro and ex vivo anti-myeloma effects of nanocomposite AsS/ZnS/FeO.

Cholujova D, Koklesova L, Lukacova Bujnakova Z, Dutkova E, Valuskova Z, Beblava P Sci Rep. 2022; 12(1):17961.

PMID: 36289430 PMC: 9606304. DOI: 10.1038/s41598-022-22672-5.

Multimodal Imaging and Phototherapy of Cancer and Bacterial Infection by Graphene and Related Nanocomposites.

Gollavelli G, Ghule A, Ling Y Molecules. 2022; 27(17).

PMID: 36080351 PMC: 9457605. DOI: 10.3390/molecules27175588.

References

Gabizon A, Shmeeda H, Barenholz Y . Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003; 42(5):419-36. DOI: 10.2165/00003088-200342050-00002. View

Attal M, Harousseau J, Stoppa A, Sotto J, Fuzibet J, Rossi J . A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. N Engl J Med. 1996; 335(2):91-7. DOI: 10.1056/NEJM199607113350204. View

Wu S, Zhao X, Li Y, Du Q, Sun J, Wang Y . Adsorption Properties of Doxorubicin Hydrochloride onto Graphene Oxide: Equilibrium, Kinetic and Thermodynamic Studies. Materials (Basel). 2017; 6(5):2026-2042. PMC: 5452512. DOI: 10.3390/ma6052026. View

Lammel T, Boisseaux P, Fernandez-Cruz M, Navas J . Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2. Part Fibre Toxicol. 2013; 10:27. PMC: 3734190. DOI: 10.1186/1743-8977-10-27. View

Pan B, Xing B . Adsorption mechanisms of organic chemicals on carbon nanotubes. Environ Sci Technol. 2009; 42(24):9005-13. DOI: 10.1021/es801777n. View

Lewinski N, Colvin V, Drezek R . Cytotoxicity of nanoparticles. Small. 2008; 4(1):26-49. DOI: 10.1002/smll.200700595. View

Kyle R, Rajkumar S . Multiple myeloma. N Engl J Med. 2004; 351(18):1860-73. DOI: 10.1056/NEJMra041875. View

AUBEL-SADRON G . Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 1984; 66(5):333-52. DOI: 10.1016/0300-9084(84)90018-x. View

Tulubas F, Gurel A, Oran M, Topcu B, Caglar V, Uygur E . The protective effects of ω-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats. Toxicol Ind Health. 2013; 31(7):638-44. DOI: 10.1177/0748233713483203. View

10.

Speth P, van Hoesel Q, Haanen C . Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet. 1988; 15(1):15-31. DOI: 10.2165/00003088-198815010-00002. View

11.

Gao Y, Li Y, Zhang L, Huang H, Hu J, Shah S . Adsorption and removal of tetracycline antibiotics from aqueous solution by graphene oxide. J Colloid Interface Sci. 2011; 368(1):540-6. DOI: 10.1016/j.jcis.2011.11.015. View

12.

Lyseng-Williamson K, Duggan S, Keating G . Pegylated liposomal doxorubicin: a guide to its use in various malignancies. BioDrugs. 2013; 27(5):533-40. DOI: 10.1007/s40259-013-0070-1. View

13.

Zhou H, Zhao K, Li W, Yang N, Liu Y, Chen C . The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-κB-related signaling pathways. Biomaterials. 2012; 33(29):6933-42. DOI: 10.1016/j.biomaterials.2012.06.064. View

14.

Chang Y, Yang S, Liu J, Dong E, Wang Y, Cao A . In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett. 2010; 200(3):201-10. DOI: 10.1016/j.toxlet.2010.11.016. View

15.

Markovic Z, Harhaji-Trajkovic L, Todorovic-Markovic B, Kepic D, Arsikin K, Jovanovic S . In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials. 2010; 32(4):1121-9. DOI: 10.1016/j.biomaterials.2010.10.030. View

16.

Brenner H, Gondos A, Pulte D . Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood. 2007; 111(5):2521-6. DOI: 10.1182/blood-2007-08-104984. View

17.

El-Sheikh A, Morsy M, Mahmoud M, Rifaai R, Abdelrahman A . Effect of coenzyme-q10 on Doxorubicin-induced nephrotoxicity in rats. Adv Pharmacol Sci. 2013; 2012:981461. PMC: 3533995. DOI: 10.1155/2012/981461. View

18.

Vallabani N, Mittal S, Shukla R, Pandey A, Dhakate S, Pasricha R . Toxicity of graphene in normal human lung cells (BEAS-2B). J Biomed Nanotechnol. 2011; 7(1):106-7. DOI: 10.1166/jbn.2011.1224. View

19.

Yang K, Wan J, Zhang S, Zhang Y, Lee S, Liu Z . In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano. 2010; 5(1):516-22. DOI: 10.1021/nn1024303. View

20.

Lin D, Xingt B . Adsorption of phenolic compounds by carbon nanotubes: role of aromaticity and substitution of hydroxyl groups. Environ Sci Technol. 2008; 42(19):7254-9. DOI: 10.1021/es801297u. View